Revance Therapeutics, Inc.
Records under this name other than the patents Revance Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 28 patents it holds.
Back to Revance Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,441,641 | Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect Term ended Term ended Jun 7, 2026 · High confidence | Term ended | Term ended Jun 7, 2026 | High confidence |
| US 9,180,081 | Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins Term ended Term ended Mar 15, 2026 · High confidence | Term ended | Term ended Mar 15, 2026 | High confidence |
| US 9,314,416 | Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins Term ended Term ended Mar 15, 2026 · High confidence | Term ended | Term ended Mar 15, 2026 | High confidence |
| US 10,080,786 | Methods for Treating Pain by Topical Application and Transdermal Delivery of Botulinum Toxin Term ended Ended no later than Mar 3, 2026 · Medium confidence | Term ended | Ended no later than Mar 3, 2026 | Medium confidence |
| US 10,744,078 | Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins Term ended Term ended Mar 3, 2026 · High confidence | Term ended | Term ended Mar 3, 2026 | High confidence |
| US 8,580,745 | Composition for therapeutic and cosmetic botulinum toxin Lapsed on the fee record Ended Nov 12, 2025 · Medium confidence | Lapsed on the fee record | Ended Nov 12, 2025 | Medium confidence |
| US 7,459,164 | Composition for Therapeutic and Cosmetic Botulinum Toxin Term ended Term ended Jul 5, 2025 · High confidence | Term ended | Term ended Jul 5, 2025 | High confidence |
| US 8,092,788 | Compositions and Methods for Topical Diagnostic and Therapeutic Transport Term ended Term ended Mar 3, 2025 · High confidence | Term ended | Term ended Mar 3, 2025 | High confidence |
| US 9,211,248 | Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins Term ended Term ended Mar 3, 2025 · High confidence | Term ended | Term ended Mar 3, 2025 | High confidence |
| US 7,270,826 | Methods of Using Botulinum Toxin for the Treatment of Hypervolemic Lip Deformity (LIP Ectropion) Term ended Term ended Jan 5, 2025 · High confidence | Term ended | Term ended Jan 5, 2025 | High confidence |